¾ÅÖÝÓ°Ôº

Explore more:

Popular searches

Donate Join us

Rob Young

Biography

I took early retirement from GSK in 2019 and set up Blue Burgundy Ltd. My 30+ years of drug discovery experience provide expertise in identifying issues and opportunities in discovery programmes, which enable my imaginative and innovative thinking to address the unique needs of every programme.

I joined Wellcome in 1990, following BA/DPhil at the University of Oxford and Post Doc at Ben May Institute, University of Chicago. Subsequent career navigated changes, mergers, and acquisitions, charting significant contributions to six development candidates in antivirals (HIV/HBV/Herpes), iNOS and Factor Xa. Moved to early stage discovery in 2006, contributing to and leading numerous successful H2L programs (HTS/Fragments/ELT).

Amongst many fruitful partnerships in international collaborations (France, Italy, Japan, Korea, USA), productive links with GSK Diseases of the Developing World group in Spain were a highlight (influential leadership in several programmes and served on SAB for EU-funded ORCHID TB consortium).

Qualifications

BA DPhil CChem FRSC

Areas of Expertise Science, engineering and technology
Legal and expert witness services
People development
Services Offered Drug discovery
Research, patents, grants and publications
Training and career development
Markets Served Pharmaceutical and medicinal
Biotechnology
Contract research organisations
Academia, charity and public sector
Professional services, publishing and technology
Geographic Regions Served Global

Contact Rob Young

Additional information

  • Drug discovery and medicinal chemistry consulting
  • Physical properties in drug design; reviews and advice
  • Objective decision making and review of drug research programmes
  • Independent review of licensing opportunities and due diligence
  • Trusted expert for scientific advisory boards
  • Patents and scientific advice relating to patent litigation
  • Scientific input to interactions with the investment community
  • Communication in plain language and by analogy
  • Teaching, mentoring and professional development
  • Pharmaceutical companies
  • Biotechnology companies
  • Contract research organizations
  • Law firms
  • Academic groups
  • Charitable Bodies (pro bono/expenses only services offered)